However, a study with a larger cohort of unselected invasive breast cancer (n = 12,467) have reported an average HER2-positive rate of 24.7%, ranging 13.7 to 35.7% across 19 different institutions from China [4]. Here, ERBB2 is linked to invasive breast carcinoma.